Advertisement

Topics

Companies Related to "Oncolytics Biotech Announces Publication REOLYSIN Abstract AACR 2018" [Most Relevant Company Matches] RSS

06:59 EDT 24th April 2018 | BioPortfolio

Here are the most relevant search results for "Oncolytics Biotech Announces Publication REOLYSIN Abstract AACR 2018" found in our extensive corporate database of over 50,000 company records.

Showing "Oncolytics Biotech Announces Publication REOLYSIN Abstract AACR 2018" Companies 1–25 of 1,200+

Extremely Relevant

Oncolytics Biotech Inc.

Oncolytics Biotech Inc. was formed in 1998 to develop its proprietary product, REOLYSIN®, as a potential therapeutic for a wide variety of human cancers. Oncolytics has completed five clinical trials with REOLYSIN® in Canada and the U.K. and is currently conducting four Phase I or Phase I/II REOLYSIN® trials in the U.K. and the U.S. The company also has permission to commence a Phase II combina...


Relevant

Epress Inc

The hallmark for advancement of scientific research is rapid dissemination of peer-reviewed information. Likewise, advancement in academic careers and success in obtaining funds for research are associated with a record of publication. However, due to space limitations, it is becoming increasingly difficult to publish scientific findings in a timely manner in conventional journals. In addition, pu...

Oncolytics

The Company's technologies are based on discoveries arising from research conducted at the University of Calgary. Dr. Coffey, VP Product Development for the Company was instrumental in these discoveries, and continues to be instrumental in the product development process. The Company was formed in 1998, to explore the natural oncolytic capability of the reovirus, a virus that preferentially replic...


ACT Biotech Inc.

ACT Biotech (www.actbiotech.com) is a San Francisco-based, privately-held biopharmaceutical company focused on the development and commercialization of targeted cancer drugs. The Company's clinical stage pipeline also includes Telatinib, the most selective oral VEGF/PDGFR/KIT inhibitor ever developed. Telatinib is currently being studied in a Phase 2 trial...

The Indian Journal of Pharmacology

The Indian Journal of Pharmacology (ISSN 0253-7613) is an official organ of the Indian Pharmacological Society. The first issue of the journal came out in 1969 and it was published quarterly. In 1997 it became a bimonthly publication. IJP publishes original research articles, reviews, research letters and correspondences. It is a peer reviewed journal indexed by Biological Abstracts/Biosys, Chemic...

American Osteopathic Association

The Journal of the American Osteopathic Association (JAOA) is the official scientific publication of the American Osteopathic Association. Edited by Robert Orenstein, DO, it is the premier scholarly peer-reviewed publication of the osteopathic medical profession. The JAOA’s mission is to advance medicine through the publication of peer-reviewed ost...

The Journal of the American Osteopathic Association

The Journal of the American Osteopathic Association (JAOA) is the official scientific publication of the American Osteopathic Association. Edited by Robert Orenstein, DO, it is the premier scholarly peer-reviewed publication of the osteopathic medical profession. The JAOA’s mission is to advance medicine through the publication of peer-reviewed ost...

Australian Prescriber

Australian Prescriber is an independent publication providing readily accessible information about drugs and therapeutics. It covers topics assisting doctors, dentists, pharmacists and students. This site provides full text versions of the publication with a search facility.

American Chiropractic Association

The American Chiropractic Association (ACA), based in Arlington, Va., is the largest professional association in the United States representing doctors of chiropractic. ACA promotes the highest standards of ethics and patient care, contributing to the health and well-being of millions of chiropractic patients. On behalf of its members, ACA lobbies for pro-chiropractic legislation and policies, ...

BIOTECH Patent News

BIOTECH Patent News is a monthly printed publication that keeps you updated on the latest events in the world of patented biotechnology. This site provides updates on the latest headlines from BIOTECH Patent News, summaries of recently issued US patents, descriptions of biotechnology available for license, and recent commentary and reviews by biotechology legal professionals. BIOTECH Patent Report...

3D Printing 2018

Operation Lifesaver Canada

WHEN: Thursday, February 22, 2018, 1:00 p.m. CST

BioTech Umeå

The Biotech industry stimulates growth and creates new job opportunities in Sweden. The city of Umeå hosts first-rate biotech research. BioTech Umeå is a driving force helping the industry as well as the region to develop and reach a greater market.

Rhein Biotech N.V.

Rhein Biotech is a globally active biotech company and the world's third largest hepatitis B vaccine manufacturer. Berna Biotech, a fully integrated vaccine focused biotechnology company acquired 92.2% of the shares of Rhein Biotech, in the year 2002. For more information on Berna Biotech please go to: http://www.bernabiotech.com/company/index.htmlRhein Biotech has been listed on the Frankfurt Sto...

M-Biotech, Inc.

M-Biotech was founded in 1997 and is located in Salt Lake City, Utah. M-Biotech's core business includes the research and development of biosensors for health care applications. Based on M-Biotech's proprietary hydrogel technology, M-Biotech focuses specifically on the development of glucose biosensors for continuous monitoring of glucose levels in diabetic patients

Nascent Biotech, Inc.

Nascent Biotech, Inc is a clinical-stage biotech company engaged in the development of monoclonal antibodies to be used in the treatment of various cancers. Its products are not commercially available. For further information please visit our website www.nascentbiotech.com.

Probably Relevant

Cella Biotech

Cella Biotech is a company that is specialized in confirming and mapping protein-protein interactions using the yeast two-hybrid system. Companies and institutions can outsource some of their protein-protein interaction work to Cella Biotech. Furthermore Cella Biotech is specialized in custom DNA construct cloning projects.

Ani Biotech Oy

Ani Biotech Oy is a Finnish biotechnology company developing, manufacturing and selling diagnostic rapid tests for laboratory, physician office and home use. Ani Biotech is now providing new optional fertility product range (MySet™) for home use for global distribution

Biotech Source Inc.

The Biotech Source" provides sales support for many small companies with specialized technical capabilities but little or no marketing presence. "The Biotech Source" offers its customers access to specialty products and services while contributing to the development of small, cutting edge technology companies. In addition, "The Biotech Source" provides an outlet for other companies to sell certain...

Rigrodsky & Long, P.A.

Rigrodsky & Long, P.A. announces that it is investigating potential legal claims against the board of directors of BioClinica, Inc. (“BioClinica” or the “Company”) (NASDAQ GM: BIOC) regarding possible breaches of fiduciary duties and other violations of law related to the Company’s entry into an agreement to be acquired by J...

International Society for Medical Publication Professionals

PBS Biotech Inc.

PBS Biotech, based in Camarillo, California, has developed the new generation PBS Single Use Bioreactors with patented unique Air-wheel™ mixing technology. PBS Biotech is one of the most innovative Companies in Southern California as testified by winning the Company of the Year Award by Pacific Coast Business Times in 2011.

BioConnection,

BioConnection, based in Oss, was established in 2005 as a joint initiative of government authorities in The Netherlands and the private industry. The company aims to be a stepping stone for young biotech companies, to promote innovation in the biotech sector and to strengthen the European biotech infrastructure.With services and manufacturing facilities available within a one-stop-shop, BioConnect...

Ortho Biotech Incorporated

Ortho Biotech Inc. is a member of the Johnson & Johnson family of companies. As a company engaged in the business of innovative research, Ortho Biotech is pleased to share with professionals and patients its resources on the subject of anemia associated with HIV therapy.

GPC Biotech

GPC Biotech AG is a publicly traded biopharmaceutical company focused on discovering, developing and commercializing new anticancer drugs. GPC Biotech's lead product candidate satraplatin is currently under review by the U.S. FDA for hormone-refractory prostate cancer patients whose prior chemotherapy has failed. Satraplatin was in-licensed from Spectrum Pharmaceuticals, Inc. GPC Biotech is also...


More From BioPortfolio on "Oncolytics Biotech Announces Publication REOLYSIN Abstract AACR 2018"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks